Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Repositioning Ivermectin for Covid-19 treatment: Molecular mechanisms of action against SARS-CoV-2 replication
Zheng Yao Low, Ashley Jia Wen Yip, Sunil K. Lal
Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease (2021) Vol. 1868, Iss. 2, pp. 166294-166294
Open Access | Times Cited: 41

Showing 1-25 of 41 citing articles:

Evolution of SARS-CoV-2 Variants: Implications on Immune Escape, Vaccination, Therapeutic and Diagnostic Strategies
Nur Zawanah Zabidi, Hern Liang Liew, Isra Ahmad Farouk, et al.
Viruses (2023) Vol. 15, Iss. 4, pp. 944-944
Open Access | Times Cited: 59
COVID-19 at a Glance: An Up-to-Date Overview on Variants, Drug Design and Therapies
Domenico Iacopetta, Jessica Ceramella, Alessia Catalano, et al.
Viruses (2022) Vol. 14, Iss. 3, pp. 573-573
Open Access | Times Cited: 49
Repurposing Molnupiravir for COVID-19: The Mechanisms of Antiviral Activity
Ashley Jia Wen Yip, Zheng Yao Low, Vincent Chow, et al.
Viruses (2022) Vol. 14, Iss. 6, pp. 1345-1345
Open Access | Times Cited: 38
SARS-CoV-2 Non-Structural Proteins and Their Roles in Host Immune Evasion
Zheng Yao Low, Nur Zawanah Zabidi, Ashley Jia Wen Yip, et al.
Viruses (2022) Vol. 14, Iss. 9, pp. 1991-1991
Open Access | Times Cited: 36
Non-Antibiotic Drug Repositioning as an Alternative Antimicrobial Approach
Alexia Barbarossa, Antonio Rosato, Filomena Corbo, et al.
Antibiotics (2022) Vol. 11, Iss. 6, pp. 816-816
Open Access | Times Cited: 33
A review on computer‐aided chemogenomics and drug repositioning for rationalCOVID‐19 drug discovery
Saeid Maghsoudi, Bahareh Taghavi Shahraki, Fatemeh Rameh, et al.
Chemical Biology & Drug Design (2022) Vol. 100, Iss. 5, pp. 699-721
Open Access | Times Cited: 33
Drug repositioning in the COVID-19 pandemic: fundamentals, synthetic routes, and overview of clinical studies
Elisa Souza Vaz, Sandra V. Vassiliades, Jeanine Giarolla, et al.
European Journal of Clinical Pharmacology (2023) Vol. 79, Iss. 6, pp. 723-751
Open Access | Times Cited: 16
Пандемия коронавируса COVID-19 и рак легкого (обзор литературы)
М.И. Бейшембаев, М.А. Азизова, У.Д. Балпаев, et al.
Scientific and practical journal Healthcare of Kyrgyzstan (2025), Iss. 4, pp. 157-163
Closed Access
COVID-19 and the Immune Response: A Multi-Phasic Approach to the Treatment of COVID-19
Tzuriel Sapir, Zaelig Averch, Brian Lerman, et al.
International Journal of Molecular Sciences (2022) Vol. 23, Iss. 15, pp. 8606-8606
Open Access | Times Cited: 23
Ivermectin for treatment of COVID-19: A systematic review and meta-analysis
Zhilong Song, Senyuan Shi, Yongli Zhang
Heliyon (2024) Vol. 10, Iss. 6, pp. e27647-e27647
Open Access | Times Cited: 4
Promising clinical outcomes of nano‐curcumin treatment as an adjunct therapy in hospitalized COVID‐19 patients: A randomized, double‐blinded, placebo‐controlled trial
Majid Sadeghizadeh, Elahe Asadollahi, Babak Jahangiri, et al.
Phytotherapy Research (2023) Vol. 37, Iss. 8, pp. 3631-3644
Closed Access | Times Cited: 11
De Novo Design of Anti-COVID Drugs Using Machine Learning-Based Equivariant Diffusion Model Targeting the Spike Protein
Vidya Niranjan, Akshay Uttarkar, Ananya Ramakrishnan, et al.
Current Issues in Molecular Biology (2023) Vol. 45, Iss. 5, pp. 4261-4284
Open Access | Times Cited: 8
Assessing the Potential Contribution of in Silico Studies in Discovering Drug Candidates that Interact with Various SARS-CoV-2 Receptors
Aganze Gloire-Aimé Mushebenge, Samuel Chima Ugbaja, Nonkululeko Avril Mbatha, et al.
(2023)
Open Access | Times Cited: 8
Why Certain Repurposed Drugs Are Unlikely to Be Effective Antivirals to Treat SARS-CoV-2 Infections
Selwyn J. Hurwitz, Ramyani De, Julia C. LeCher, et al.
Viruses (2024) Vol. 16, Iss. 4, pp. 651-651
Open Access | Times Cited: 2
14‐3‐3 Family of Proteins: Biological Implications, Molecular Interactions, and Potential Intervention in Cancer, Virus and Neurodegeneration Disorders
Zheng Yao Low, Ashley Jia Wen Yip, Alvin Man Lung Chan, et al.
Journal of Cellular Biochemistry (2024) Vol. 125, Iss. 7
Open Access | Times Cited: 2
VIRAL DISEASES AND THE ENVIRONMENT RELATIONSHIP
Caio Gonçalves do Amaral, Eduardo Pinto André, Eduardo Maffud Cilli, et al.
Environmental Pollution (2024), pp. 124845-124845
Closed Access | Times Cited: 2
Non-effectiveness of Ivermectin on Inpatients and Outpatients With COVID-19; Results of Two Randomized, Double-Blinded, Placebo-Controlled Clinical Trials
Mohammad Sadegh Rezai, Fatemeh Ahangarkani, Andrew Hill, et al.
Frontiers in Medicine (2022) Vol. 9
Open Access | Times Cited: 12
Antiviral Activity of Repurposing Ivermectin against a Panel of 30 Clinical SARS-CoV-2 Strains Belonging to 14 Variants
Océane Delandre, Mathieu Gendrot, Priscilla Jardot, et al.
Pharmaceuticals (2022) Vol. 15, Iss. 4, pp. 445-445
Open Access | Times Cited: 10
[(EtO)3Si(CH2)3N+H3][CH3COO−] as Basic Ionic Liquid Catalyst Promoted Green Synthesis of Benzo[a]pyrano[2,3-c]phenazine Derivatives in Homogenous Solution
Farhad Shirzaei, Hamid Reza Shaterian
Journal of Solution Chemistry (2023) Vol. 53, Iss. 2, pp. 328-340
Closed Access | Times Cited: 5
A perspective study of the possible impact of obeticholic acid against SARS-CoV-2 infection
Gaber El‐Saber Batiha, Hayder M. Al‐kuraishy, Ali I. Al‐Gareeb, et al.
Inflammopharmacology (2022) Vol. 31, Iss. 1, pp. 9-19
Open Access | Times Cited: 9
Ivermectin ameliorates acute myocarditis via the inhibition of importin-mediated nuclear translocation of NF-κB/p65
Xu Gao, Yunling Xuan, Zhou Zhou, et al.
International Immunopharmacology (2024) Vol. 133, pp. 112073-112073
Closed Access | Times Cited: 1
Optical coherence tomography findings in presumed veterinary anthelmintic drug-induced retinal toxicity: a glimpse into underlying mechanism
Wenxue Guan, Xufeng Zhao, Weihong Yu, et al.
Retina (2024)
Closed Access | Times Cited: 1
A deep learning framework for predicting molecular property based on multi-type features fusion
Mei Ma, Xiujuan Lei
Computers in Biology and Medicine (2023) Vol. 169, pp. 107911-107911
Closed Access | Times Cited: 4
Ivermectin: A Controversial Focal Point during the COVID-19 Pandemic
Manuel Castillejos‐López, Luz María Torres‐Espíndola, Juan Carlos Huerta‐Cruz, et al.
Life (2022) Vol. 12, Iss. 9, pp. 1384-1384
Open Access | Times Cited: 7
Interaction of the new inhibitor paxlovid (PF-07321332) and ivermectin with the monomer of the main protease SARS-CoV-2: A volumetric study based on molecular dynamics, elastic networks, classical thermodynamics and SPT
Ysaías J. Alvarado, Yosmari Olivarez, Carla Lossada, et al.
Computational Biology and Chemistry (2022) Vol. 99, pp. 107692-107692
Open Access | Times Cited: 5
Page 1 - Next Page

Scroll to top